TrialApoptosis : an international journal on programmed cell death2011

Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.

J E Arends et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.